KYNB
Income statement / Annual
Last year (2025), Kyntra Bio Inc.'s total revenue was $6.44 M,
a decrease of 78.26% from the previous year.
In 2025, Kyntra Bio Inc.'s net income was $183.45 M.
See Kyntra Bio Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$6.44 M |
$29.62 M |
$46.80 M |
$140.73 M |
$235.31 M |
$176.32 M |
$256.58 M |
$212.96 M |
$125.67 M |
$179.58 M |
| Cost of Revenue |
$556.00 K
|
$15.56 M
|
$3.96 M
|
$20.28 M
|
$449.19 M
|
$8.87 M
|
$1.15 M
|
$235.84 M
|
$196.52 M
|
$187.21 M
|
| Gross Profit |
$5.88 M
|
$14.06 M
|
$42.84 M
|
$120.45 M
|
-$213.88 M
|
$167.45 M
|
$255.43 M
|
-$22.88 M
|
-$70.85 M
|
-$7.63 M
|
| Gross Profit Ratio |
0.91
|
0.47
|
0.92
|
0.86
|
-0.91
|
0.95
|
1
|
-0.11
|
-0.56
|
-0.04
|
| Research and Development Expenses |
$23.52 M
|
$95.69 M
|
$266.47 M
|
$296.79 M
|
$387.04 M
|
$252.92 M
|
$209.27 M
|
$235.84 M
|
$196.52 M
|
$187.21 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$63.81 M
|
$51.76 M
|
$46.03 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$27.71 M
|
$49.33 M
|
$86.48 M
|
$124.69 M
|
$0.00
|
$106.41 M
|
$135.48 M
|
$63.81 M
|
$51.76 M
|
$46.03 M
|
| Other Expenses |
$553.00 K
|
$19.45 M
|
$12.61 M
|
$0.00
|
-$312.40 M
|
$0.00
|
$0.00
|
$42.16 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$51.78 M
|
$164.48 M
|
$365.56 M
|
$421.48 M
|
$74.65 M
|
$359.33 M
|
$344.74 M
|
$299.65 M
|
$248.28 M
|
$233.23 M
|
| Cost And Expenses |
$52.34 M
|
$180.04 M
|
$369.52 M
|
$441.76 M
|
$523.84 M
|
$368.20 M
|
$345.89 M
|
$299.65 M
|
$248.28 M
|
$233.23 M
|
| Interest Income |
$2.94 M
|
$5.30 M
|
$7.59 M
|
$7.60 M
|
$0.00
|
$5.55 M
|
$15.55 M
|
$11.57 M
|
$6.43 M
|
$2.63 M
|
| Interest Expense |
$8.76 M
|
$8.25 M
|
$8.10 M
|
$1.44 M
|
$1.08 M
|
$2.40 M
|
$2.88 M
|
$10.99 M
|
$9.71 M
|
$10.73 M
|
| Depreciation & Amortization |
$748.00 K
|
$2.69 M
|
$9.93 M
|
$10.60 M
|
$14.81 M
|
$22.05 M
|
$21.45 M
|
$6.56 M
|
$6.10 M
|
$6.04 M
|
| EBITDA |
-$57.55 M |
-$142.43 M |
-$305.20 M |
-$282.83 M |
-$333.72 M |
-$164.28 M |
-$52.31 M |
-$68.56 M |
-$104.75 M |
-$44.99 M |
| EBITDA Ratio |
-8.94
|
-4.81
|
-6.52
|
-2.01
|
-1.42
|
-0.93
|
-0.2
|
-0.32
|
-0.83
|
-0.25
|
| Operating Income Ratio |
-7.13
|
-5.08
|
-6.9
|
-2.14
|
-1.23
|
-1.09
|
-0.35
|
-0.41
|
-0.98
|
-0.3
|
| Total Other Income/Expenses Net |
-$12.40 M
|
-$2.95 M
|
-$501.00 K
|
$7.73 M
|
-$1.15 M
|
$2.95 M
|
$12.67 M
|
$577.00 K
|
-$3.27 M
|
-$8.10 M
|
| Income Before Tax |
-$58.29 M
|
-$153.37 M
|
-$323.22 M
|
-$293.30 M
|
-$289.68 M
|
-$188.93 M
|
-$76.64 M
|
-$86.12 M
|
-$125.88 M
|
-$61.75 M
|
| Income Before Tax Ratio |
-9.05
|
-5.18
|
-6.91
|
-2.08
|
-1.23
|
-1.07
|
-0.3
|
-0.4
|
-1
|
-0.34
|
| Income Tax Expense |
-$90.00 K
|
-$269.00 K
|
-$252.00 K
|
$358.00 K
|
$347.00 K
|
$360.00 K
|
$328.00 K
|
$304.00 K
|
$321.00 K
|
-$71.00 K
|
| Net Income |
$183.45 M
|
-$47.58 M
|
-$284.23 M
|
-$293.65 M
|
-$290.02 M
|
-$189.29 M
|
-$76.97 M
|
-$86.42 M
|
-$126.20 M
|
-$61.68 M
|
| Net Income Ratio |
28.49
|
-1.61
|
-6.07
|
-2.09
|
-1.23
|
-1.07
|
-0.3
|
-0.41
|
-1
|
-0.34
|
| EPS |
45.37 |
-0.48 |
-2.92 |
-3.15 |
-3.15 |
-2.11 |
-0.89 |
-1.03 |
-1.73 |
-0.98 |
| EPS Diluted |
45.37 |
-0.48 |
-2.92 |
-3.15 |
-3.15 |
-2.11 |
-0.89 |
-1.03 |
-1.73 |
-0.98 |
| Weighted Average Shares Out |
$4.04 M
|
$100.04 M
|
$97.30 M
|
$93.58 M
|
$92.35 M
|
$89.85 M
|
$86.63 M
|
$84.06 M
|
$72.99 M
|
$62.74 M
|
| Weighted Average Shares Out Diluted |
$4.04 M
|
$100.04 M
|
$97.30 M
|
$93.58 M
|
$92.35 M
|
$89.85 M
|
$86.63 M
|
$84.06 M
|
$72.99 M
|
$62.74 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
